

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 7.03442993 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.83320034 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.62190142 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.50703837 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.16914803 |
| 6 | glycine transport (GO:0015816) | 5.13048934 |
| 7 | glutamate secretion (GO:0014047) | 4.95571669 |
| 8 | cerebellar granule cell differentiation (GO:0021707) | 4.93597656 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.86860584 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.82230402 |
| 11 | vocalization behavior (GO:0071625) | 4.74092919 |
| 12 | sodium ion export (GO:0071436) | 4.54919292 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.53425036 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.52440892 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.50593238 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.48302484 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 4.40523037 |
| 18 | regulation of synapse structural plasticity (GO:0051823) | 4.38470776 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.35509791 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.32488793 |
| 21 | gamma-aminobutyric acid transport (GO:0015812) | 4.29202370 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 4.27051305 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24233638 |
| 24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21156431 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.11293861 |
| 26 | proline transport (GO:0015824) | 4.09786367 |
| 27 | neuromuscular process controlling posture (GO:0050884) | 4.08355780 |
| 28 | exploration behavior (GO:0035640) | 4.04995108 |
| 29 | positive regulation of dendritic spine development (GO:0060999) | 4.03867900 |
| 30 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.99242269 |
| 31 | postsynaptic membrane organization (GO:0001941) | 3.98910890 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.96415222 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.91219494 |
| 34 | protein localization to synapse (GO:0035418) | 3.89606496 |
| 35 | L-amino acid import (GO:0043092) | 3.86313618 |
| 36 | dendritic spine morphogenesis (GO:0060997) | 3.85970695 |
| 37 | neuromuscular process controlling balance (GO:0050885) | 3.82737388 |
| 38 | regulation of synapse maturation (GO:0090128) | 3.82511763 |
| 39 | neurotransmitter transport (GO:0006836) | 3.78988950 |
| 40 | activation of protein kinase A activity (GO:0034199) | 3.73353314 |
| 41 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.71826102 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.71562998 |
| 43 | potassium ion import (GO:0010107) | 3.70266767 |
| 44 | long-term memory (GO:0007616) | 3.59207917 |
| 45 | cell communication by electrical coupling (GO:0010644) | 3.58773201 |
| 46 | central nervous system myelination (GO:0022010) | 3.57254051 |
| 47 | axon ensheathment in central nervous system (GO:0032291) | 3.57254051 |
| 48 | synaptic transmission, glutamatergic (GO:0035249) | 3.57222079 |
| 49 | neuron cell-cell adhesion (GO:0007158) | 3.51070308 |
| 50 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.49573637 |
| 51 | regulation of neurotransmitter levels (GO:0001505) | 3.48672666 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 3.47575993 |
| 53 | auditory behavior (GO:0031223) | 3.44854909 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.40348710 |
| 55 | potassium ion homeostasis (GO:0055075) | 3.38118547 |
| 56 | glutamate receptor signaling pathway (GO:0007215) | 3.35704683 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.35532208 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.32520891 |
| 59 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32231103 |
| 60 | prepulse inhibition (GO:0060134) | 3.29750107 |
| 61 | response to auditory stimulus (GO:0010996) | 3.29456256 |
| 62 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.28769898 |
| 63 | acidic amino acid transport (GO:0015800) | 3.27504073 |
| 64 | neuronal ion channel clustering (GO:0045161) | 3.27480928 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.26572432 |
| 66 | cerebellar Purkinje cell layer development (GO:0021680) | 3.26373098 |
| 67 | regulation of dendritic spine development (GO:0060998) | 3.24815332 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.24300876 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.24230462 |
| 70 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.22829573 |
| 71 | adult walking behavior (GO:0007628) | 3.19967858 |
| 72 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.18387686 |
| 73 | regulation of synaptic transmission (GO:0050804) | 3.16608244 |
| 74 | vesicle docking involved in exocytosis (GO:0006904) | 3.16602764 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 3.14621659 |
| 76 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12387562 |
| 77 | neurotransmitter uptake (GO:0001504) | 3.11603685 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10937350 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 3.09412331 |
| 80 | positive regulation of dendrite development (GO:1900006) | 3.08603515 |
| 81 | regulation of postsynaptic membrane potential (GO:0060078) | 3.07772885 |
| 82 | vesicle transport along microtubule (GO:0047496) | 3.07036905 |
| 83 | neuromuscular process (GO:0050905) | 3.05908863 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05566575 |
| 85 | membrane depolarization during action potential (GO:0086010) | 3.02854024 |
| 86 | negative regulation of microtubule polymerization (GO:0031115) | 3.02231735 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01898438 |
| 88 | dicarboxylic acid transport (GO:0006835) | 3.00322323 |
| 89 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.99755474 |
| 90 | synaptic vesicle transport (GO:0048489) | 2.99391839 |
| 91 | establishment of synaptic vesicle localization (GO:0097480) | 2.99391839 |
| 92 | membrane hyperpolarization (GO:0060081) | 2.99187654 |
| 93 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.98927497 |
| 94 | regulation of neurotransmitter transport (GO:0051588) | 2.98866520 |
| 95 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.98851411 |
| 96 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.98798851 |
| 97 | synaptic vesicle endocytosis (GO:0048488) | 2.98357166 |
| 98 | amino acid import (GO:0043090) | 2.97995948 |
| 99 | cell differentiation in hindbrain (GO:0021533) | 2.97782508 |
| 100 | dendrite morphogenesis (GO:0048813) | 2.97655427 |
| 101 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93796651 |
| 102 | positive regulation of synapse maturation (GO:0090129) | 2.92996236 |
| 103 | mating behavior (GO:0007617) | 2.92783585 |
| 104 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91467716 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 2.91131962 |
| 106 | regulation of exocytosis (GO:0017157) | 2.90530612 |
| 107 | L-glutamate transport (GO:0015813) | 2.90092029 |
| 108 | positive regulation of neurotransmitter transport (GO:0051590) | 2.89835774 |
| 109 | neuron recognition (GO:0008038) | 2.88398384 |
| 110 | cell communication involved in cardiac conduction (GO:0086065) | 2.84327232 |
| 111 | positive regulation of potassium ion transport (GO:0043268) | 2.83947689 |
| 112 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.81622910 |
| 113 | dendritic spine organization (GO:0097061) | 2.81055438 |
| 114 | organelle transport along microtubule (GO:0072384) | 2.81024523 |
| 115 | axon cargo transport (GO:0008088) | 2.80921624 |
| 116 | long-term synaptic potentiation (GO:0060291) | 2.79821109 |
| 117 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.79228357 |
| 118 | membrane depolarization (GO:0051899) | 2.78913693 |
| 119 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78106398 |
| 120 | cell migration in hindbrain (GO:0021535) | 2.74890663 |
| 121 | regulation of vesicle fusion (GO:0031338) | 2.74415649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.00565193 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.05082791 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93797686 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92108959 |
| 5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80848693 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80848693 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77933796 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.76126842 |
| 9 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.75987662 |
| 10 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.71120101 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.66755921 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55467921 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54362117 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53660169 |
| 15 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39481856 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35987520 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32304662 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27639612 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27531720 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23550391 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19355989 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18534251 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.06639380 |
| 24 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.02358394 |
| 25 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98163844 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88069257 |
| 27 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.84269991 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.83703134 |
| 29 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.78818356 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.74949536 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71102667 |
| 32 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.68321729 |
| 33 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.67685368 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.60184573 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56794802 |
| 36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54119217 |
| 37 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.53507770 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53304961 |
| 39 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.51078584 |
| 40 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49272675 |
| 41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.46182042 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44780342 |
| 43 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.44541815 |
| 44 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.40723801 |
| 45 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34791142 |
| 46 | * P68_20966046_ChIP-Seq_HELA_Human | 1.31354308 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29892651 |
| 48 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.29683650 |
| 49 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25850636 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24800955 |
| 51 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23529440 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23281220 |
| 53 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23038855 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22866507 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20720054 |
| 56 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.18748899 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18696225 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17722582 |
| 59 | AR_19668381_ChIP-Seq_PC3_Human | 1.17312124 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16827362 |
| 61 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16334180 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14505017 |
| 63 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.11852442 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11675409 |
| 65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11225058 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.09703482 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09571556 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08349817 |
| 69 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05856382 |
| 70 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.04438333 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04262573 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03948234 |
| 73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02017409 |
| 74 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01876182 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99539030 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98658664 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98491899 |
| 78 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98467464 |
| 79 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98252540 |
| 80 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.97976379 |
| 81 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97935122 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97208103 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97206242 |
| 84 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.97097191 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96834713 |
| 86 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96475779 |
| 87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96448528 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95741541 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94096001 |
| 90 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93942033 |
| 91 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.93875135 |
| 92 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.92958477 |
| 93 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91796772 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91511145 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91457348 |
| 96 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91279480 |
| 97 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91017275 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90995425 |
| 99 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89210939 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88511837 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87843503 |
| 102 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87204556 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.87123154 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86870389 |
| 105 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86608064 |
| 106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86058055 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84344209 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84165471 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83704620 |
| 110 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.83697388 |
| 111 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83092562 |
| 112 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.82762768 |
| 113 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82574497 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81942871 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81750852 |
| 116 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.81669942 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81514977 |
| 118 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.81095249 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79625311 |
| 120 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.79399733 |
| 121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78743291 |
| 122 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78175427 |
| 123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77967445 |
| 124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77360284 |
| 125 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77054514 |
| 126 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.76590335 |
| 127 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.75714772 |
| 128 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74595711 |
| 129 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74252093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.35376425 |
| 2 | MP0003880_abnormal_central_pattern | 4.49648978 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.99006658 |
| 4 | MP0004270_analgesia | 3.61727580 |
| 5 | MP0002822_catalepsy | 3.24184620 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.14067294 |
| 7 | * MP0002064_seizures | 3.13645531 |
| 8 | MP0009046_muscle_twitch | 3.12563102 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.09095940 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.91952038 |
| 11 | MP0001486_abnormal_startle_reflex | 2.73026274 |
| 12 | * MP0002272_abnormal_nervous_system | 2.64798749 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.48315380 |
| 14 | * MP0002572_abnormal_emotion/affect_behav | 2.48201218 |
| 15 | MP0004858_abnormal_nervous_system | 2.47846155 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.36648545 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.28582813 |
| 18 | MP0008569_lethality_at_weaning | 2.21814470 |
| 19 | MP0003329_amyloid_beta_deposits | 2.13887936 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.07317958 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.00047853 |
| 22 | MP0001970_abnormal_pain_threshold | 1.98513202 |
| 23 | MP0004885_abnormal_endolymph | 1.94460033 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.86416442 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.82387872 |
| 26 | MP0000955_abnormal_spinal_cord | 1.81075043 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.78148162 |
| 28 | MP0000920_abnormal_myelination | 1.74614942 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.69662813 |
| 30 | MP0004142_abnormal_muscle_tone | 1.69370849 |
| 31 | MP0003123_paternal_imprinting | 1.68696231 |
| 32 | MP0003633_abnormal_nervous_system | 1.63700587 |
| 33 | MP0004924_abnormal_behavior | 1.58213749 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.58213749 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.57672086 |
| 36 | MP0002184_abnormal_innervation | 1.57573893 |
| 37 | MP0002736_abnormal_nociception_after | 1.57552605 |
| 38 | MP0003690_abnormal_glial_cell | 1.57046436 |
| 39 | MP0000778_abnormal_nervous_system | 1.55269024 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.50210075 |
| 41 | MP0003283_abnormal_digestive_organ | 1.46434273 |
| 42 | * MP0002066_abnormal_motor_capabilities/c | 1.46306581 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.41573639 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.39613102 |
| 45 | MP0003122_maternal_imprinting | 1.33850418 |
| 46 | MP0003631_nervous_system_phenotype | 1.33507329 |
| 47 | MP0000751_myopathy | 1.30426338 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.30123048 |
| 49 | MP0003634_abnormal_glial_cell | 1.28631554 |
| 50 | MP0004043_abnormal_pH_regulation | 1.27569764 |
| 51 | MP0003787_abnormal_imprinting | 1.23932467 |
| 52 | MP0005623_abnormal_meninges_morphology | 1.22700595 |
| 53 | MP0003075_altered_response_to | 1.20934290 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.20430894 |
| 55 | MP0002229_neurodegeneration | 1.19835993 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.18872752 |
| 57 | MP0001529_abnormal_vocalization | 1.15986252 |
| 58 | MP0005499_abnormal_olfactory_system | 1.15835196 |
| 59 | MP0005394_taste/olfaction_phenotype | 1.15835196 |
| 60 | MP0001984_abnormal_olfaction | 1.15826327 |
| 61 | MP0003879_abnormal_hair_cell | 1.15166974 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.11865477 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.07422757 |
| 64 | MP0008872_abnormal_physiological_respon | 1.05833073 |
| 65 | MP0002152_abnormal_brain_morphology | 1.04650630 |
| 66 | MP0003632_abnormal_nervous_system | 1.04414719 |
| 67 | MP0000579_abnormal_nail_morphology | 1.00889941 |
| 68 | MP0001905_abnormal_dopamine_level | 1.00546803 |
| 69 | MP0008874_decreased_physiological_sensi | 0.99160027 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.99146313 |
| 71 | MP0001502_abnormal_circadian_rhythm | 0.96715495 |
| 72 | MP0004215_abnormal_myocardial_fiber | 0.93679325 |
| 73 | MP0003172_abnormal_lysosome_physiology | 0.91553745 |
| 74 | MP0000604_amyloidosis | 0.91553074 |
| 75 | * MP0004085_abnormal_heartbeat | 0.90658418 |
| 76 | MP0006276_abnormal_autonomic_nervous | 0.90545299 |
| 77 | MP0005409_darkened_coat_color | 0.90313798 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.89366143 |
| 79 | * MP0003137_abnormal_impulse_conducting | 0.89178195 |
| 80 | MP0000747_muscle_weakness | 0.87711800 |
| 81 | MP0001177_atelectasis | 0.86546686 |
| 82 | MP0002069_abnormal_eating/drinking_beha | 0.84620791 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 0.84505046 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.81859381 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.80704759 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.78185707 |
| 87 | MP0004742_abnormal_vestibular_system | 0.75868506 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.74423376 |
| 89 | MP0004130_abnormal_muscle_cell | 0.72696143 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.72371632 |
| 91 | MP0004484_altered_response_of | 0.72074755 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.71791910 |
| 93 | MP0005535_abnormal_body_temperature | 0.71518341 |
| 94 | MP0003646_muscle_fatigue | 0.69763859 |
| 95 | MP0004233_abnormal_muscle_weight | 0.69445995 |
| 96 | MP0002090_abnormal_vision | 0.68773063 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.67327198 |
| 98 | MP0004510_myositis | 0.67059674 |
| 99 | MP0000749_muscle_degeneration | 0.63999476 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.63989392 |
| 101 | MP0004036_abnormal_muscle_relaxation | 0.62373276 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.60648223 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.59718065 |
| 104 | MP0004084_abnormal_cardiac_muscle | 0.59185205 |
| 105 | MP0001943_abnormal_respiration | 0.58542190 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.57460269 |
| 107 | MP0001188_hyperpigmentation | 0.56932428 |
| 108 | MP0003861_abnormal_nervous_system | 0.56928979 |
| 109 | MP0010769_abnormal_survival | 0.55975769 |
| 110 | MP0008260_abnormal_autophagy | 0.55192117 |
| 111 | MP0002269_muscular_atrophy | 0.55127666 |
| 112 | MP0010770_preweaning_lethality | 0.53503266 |
| 113 | MP0002082_postnatal_lethality | 0.53503266 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.52917039 |
| 115 | MP0010768_mortality/aging | 0.51590183 |
| 116 | * MP0003956_abnormal_body_size | 0.51468051 |
| 117 | MP0004147_increased_porphyrin_level | 0.51430763 |
| 118 | MP0005166_decreased_susceptibility_to | 0.50346733 |
| 119 | MP0001731_abnormal_postnatal_growth | 0.49723647 |
| 120 | MP0000462_abnormal_digestive_system | 0.48849577 |
| 121 | MP0002873_normal_phenotype | 0.47241578 |
| 122 | MP0002169_no_abnormal_phenotype | 0.45467119 |
| 123 | MP0005171_absent_coat_pigmentation | 0.45070809 |
| 124 | MP0009672_abnormal_birth_weight | 0.41110708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.82394516 |
| 2 | Focal motor seizures (HP:0011153) | 5.61692503 |
| 3 | Focal seizures (HP:0007359) | 4.76427146 |
| 4 | Visual hallucinations (HP:0002367) | 4.69128610 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 4.52067934 |
| 6 | Action tremor (HP:0002345) | 4.30431662 |
| 7 | Ankle clonus (HP:0011448) | 4.16111944 |
| 8 | Obstructive sleep apnea (HP:0002870) | 3.98324366 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 3.69048676 |
| 10 | Atonic seizures (HP:0010819) | 3.54029778 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.52872930 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.47939457 |
| 13 | Febrile seizures (HP:0002373) | 3.42669865 |
| 14 | Depression (HP:0000716) | 3.40751739 |
| 15 | Ventricular fibrillation (HP:0001663) | 3.31655578 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.30825805 |
| 17 | Postural instability (HP:0002172) | 3.29417131 |
| 18 | Dysmetria (HP:0001310) | 3.21498041 |
| 19 | Intention tremor (HP:0002080) | 3.16375692 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.15088902 |
| 21 | Absence seizures (HP:0002121) | 3.12096307 |
| 22 | Akinesia (HP:0002304) | 3.08215670 |
| 23 | Dialeptic seizures (HP:0011146) | 3.07494116 |
| 24 | Neurofibrillary tangles (HP:0002185) | 2.98218371 |
| 25 | Torticollis (HP:0000473) | 2.96526432 |
| 26 | Poor eye contact (HP:0000817) | 2.95819957 |
| 27 | Urinary urgency (HP:0000012) | 2.93760743 |
| 28 | Mutism (HP:0002300) | 2.93033025 |
| 29 | Spastic gait (HP:0002064) | 2.92692965 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.88029405 |
| 31 | Anxiety (HP:0000739) | 2.85869522 |
| 32 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.85455644 |
| 33 | Delusions (HP:0000746) | 2.83210334 |
| 34 | Bundle branch block (HP:0011710) | 2.79507450 |
| 35 | Abnormal social behavior (HP:0012433) | 2.78936255 |
| 36 | Impaired social interactions (HP:0000735) | 2.78936255 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 2.78508339 |
| 38 | Insomnia (HP:0100785) | 2.75797497 |
| 39 | Peripheral hypomyelination (HP:0007182) | 2.69540604 |
| 40 | Papilledema (HP:0001085) | 2.67391919 |
| 41 | Annular pancreas (HP:0001734) | 2.67059058 |
| 42 | Hemiparesis (HP:0001269) | 2.65274024 |
| 43 | Hemiplegia (HP:0002301) | 2.62506954 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.60621474 |
| 45 | Abnormal eating behavior (HP:0100738) | 2.60421731 |
| 46 | Truncal ataxia (HP:0002078) | 2.56171975 |
| 47 | Resting tremor (HP:0002322) | 2.55922440 |
| 48 | Scanning speech (HP:0002168) | 2.55675965 |
| 49 | Megalencephaly (HP:0001355) | 2.55308178 |
| 50 | Focal dystonia (HP:0004373) | 2.54492512 |
| 51 | Diminished motivation (HP:0000745) | 2.54270876 |
| 52 | Amblyopia (HP:0000646) | 2.52364596 |
| 53 | Pheochromocytoma (HP:0002666) | 2.51793903 |
| 54 | Termporal pattern (HP:0011008) | 2.50148683 |
| 55 | Insidious onset (HP:0003587) | 2.50148683 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.47371571 |
| 57 | Lower limb muscle weakness (HP:0007340) | 2.46748280 |
| 58 | Broad-based gait (HP:0002136) | 2.43306306 |
| 59 | Onion bulb formation (HP:0003383) | 2.41603263 |
| 60 | Craniofacial dystonia (HP:0012179) | 2.40716515 |
| 61 | Bradykinesia (HP:0002067) | 2.39030792 |
| 62 | Hyperacusis (HP:0010780) | 2.39023510 |
| 63 | Clonus (HP:0002169) | 2.36439912 |
| 64 | Tetraplegia (HP:0002445) | 2.31769879 |
| 65 | Sleep apnea (HP:0010535) | 2.26891466 |
| 66 | Genetic anticipation (HP:0003743) | 2.25104501 |
| 67 | Limb dystonia (HP:0002451) | 2.23715172 |
| 68 | Rapidly progressive (HP:0003678) | 2.23617336 |
| 69 | Abnormal EKG (HP:0003115) | 2.22176877 |
| 70 | Neuronal loss in central nervous system (HP:0002529) | 2.21719944 |
| 71 | Epileptiform EEG discharges (HP:0011182) | 2.21538227 |
| 72 | Amyotrophic lateral sclerosis (HP:0007354) | 2.21219790 |
| 73 | Impaired smooth pursuit (HP:0007772) | 2.19745708 |
| 74 | Choreoathetosis (HP:0001266) | 2.19143802 |
| 75 | Dysmetric saccades (HP:0000641) | 2.18227212 |
| 76 | Spastic tetraparesis (HP:0001285) | 2.17651704 |
| 77 | Status epilepticus (HP:0002133) | 2.17129459 |
| 78 | Lower limb asymmetry (HP:0100559) | 2.14088938 |
| 79 | Cerebral hypomyelination (HP:0006808) | 2.12015182 |
| 80 | Spinal canal stenosis (HP:0003416) | 2.11778462 |
| 81 | Pointed chin (HP:0000307) | 2.11255364 |
| 82 | Upper limb amyotrophy (HP:0009129) | 2.10704872 |
| 83 | Distal upper limb amyotrophy (HP:0007149) | 2.10704872 |
| 84 | Diplopia (HP:0000651) | 2.09062213 |
| 85 | Abnormality of binocular vision (HP:0011514) | 2.09062213 |
| 86 | Neoplasm of the heart (HP:0100544) | 2.08086816 |
| 87 | Achilles tendon contracture (HP:0001771) | 2.07543221 |
| 88 | Hand muscle atrophy (HP:0009130) | 2.06972251 |
| 89 | Lower limb amyotrophy (HP:0007210) | 2.06901674 |
| 90 | Abnormality of saccadic eye movements (HP:0000570) | 2.06323932 |
| 91 | Abnormality of the periventricular white matter (HP:0002518) | 2.05688205 |
| 92 | Rigidity (HP:0002063) | 2.05320706 |
| 93 | Hyperventilation (HP:0002883) | 2.04010370 |
| 94 | Neuroendocrine neoplasm (HP:0100634) | 2.03745811 |
| 95 | Turricephaly (HP:0000262) | 2.03451455 |
| 96 | Prolonged QT interval (HP:0001657) | 2.02557696 |
| 97 | Difficulty running (HP:0009046) | 2.02487354 |
| 98 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.01308014 |
| 99 | Progressive inability to walk (HP:0002505) | 2.01247415 |
| 100 | CNS hypomyelination (HP:0003429) | 1.99150569 |
| 101 | Drooling (HP:0002307) | 1.97043061 |
| 102 | Excessive salivation (HP:0003781) | 1.97043061 |
| 103 | Stereotypic behavior (HP:0000733) | 1.96449128 |
| 104 | Impaired vibratory sensation (HP:0002495) | 1.96329712 |
| 105 | Dysphonia (HP:0001618) | 1.95872814 |
| 106 | Apathy (HP:0000741) | 1.92444496 |
| 107 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92025725 |
| 108 | Aplasia involving bones of the extremities (HP:0009825) | 1.91713880 |
| 109 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.91713880 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 1.91713880 |
| 111 | Heart block (HP:0012722) | 1.91097347 |
| 112 | Generalized hypotonia (HP:0001290) | 1.91079997 |
| 113 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.90094851 |
| 114 | Distal sensory impairment (HP:0002936) | 1.89583256 |
| 115 | Generalized myoclonic seizures (HP:0002123) | 1.89292371 |
| 116 | Hammertoe (HP:0001765) | 1.89179307 |
| 117 | Abnormal atrioventricular conduction (HP:0005150) | 1.87581455 |
| 118 | Overriding aorta (HP:0002623) | 1.87104548 |
| 119 | Foot dorsiflexor weakness (HP:0009027) | 1.86232785 |
| 120 | Dementia (HP:0000726) | 1.83991639 |
| 121 | Incomplete penetrance (HP:0003829) | 1.83935194 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.78512088 |
| 123 | Slow saccadic eye movements (HP:0000514) | 1.78296513 |
| 124 | Slow progression (HP:0003677) | 1.77893459 |
| 125 | Hypsarrhythmia (HP:0002521) | 1.76514632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.86708562 |
| 2 | NTRK3 | 3.61077397 |
| 3 | EPHA4 | 3.54701473 |
| 4 | PRKD3 | 3.04484796 |
| 5 | PAK6 | 2.61208041 |
| 6 | NTRK1 | 2.58111566 |
| 7 | MINK1 | 2.39293355 |
| 8 | MAP3K4 | 2.37246444 |
| 9 | MARK1 | 2.36368588 |
| 10 | KSR2 | 2.34639348 |
| 11 | GRK5 | 2.26788593 |
| 12 | CAMKK1 | 2.19139339 |
| 13 | DAPK2 | 2.07193039 |
| 14 | TYRO3 | 2.01379156 |
| 15 | NTRK2 | 1.92769715 |
| 16 | STK38 | 1.79198925 |
| 17 | WNK1 | 1.75795798 |
| 18 | MAP2K4 | 1.75390027 |
| 19 | UHMK1 | 1.72201318 |
| 20 | LMTK2 | 1.57502076 |
| 21 | MAP2K7 | 1.51604119 |
| 22 | PHKG1 | 1.48348909 |
| 23 | PHKG2 | 1.48348909 |
| 24 | CDK5 | 1.47627693 |
| 25 | PINK1 | 1.41483960 |
| 26 | ALK | 1.39497770 |
| 27 | CDK19 | 1.31602838 |
| 28 | MAP3K2 | 1.22940058 |
| 29 | TAOK1 | 1.21895864 |
| 30 | PRKCH | 1.18752347 |
| 31 | RIPK4 | 1.14148663 |
| 32 | SGK494 | 1.13242564 |
| 33 | SGK223 | 1.13242564 |
| 34 | RIPK1 | 1.12810301 |
| 35 | CAMKK2 | 1.06552419 |
| 36 | LATS2 | 1.05402581 |
| 37 | MARK2 | 1.03204183 |
| 38 | STK11 | 1.02563563 |
| 39 | PRKCG | 1.01492572 |
| 40 | TESK1 | 1.01113802 |
| 41 | MAPK12 | 0.96521214 |
| 42 | FES | 0.96076562 |
| 43 | ARAF | 0.96029340 |
| 44 | CDK15 | 0.95726695 |
| 45 | CAMK1 | 0.95578917 |
| 46 | KSR1 | 0.95518669 |
| 47 | RET | 0.94194637 |
| 48 | BRAF | 0.93468556 |
| 49 | PAK3 | 0.92145697 |
| 50 | CDK18 | 0.91736300 |
| 51 | SIK2 | 0.90020573 |
| 52 | CDK14 | 0.88245470 |
| 53 | PRPF4B | 0.88179165 |
| 54 | NEK1 | 0.87494410 |
| 55 | CAMK2B | 0.84721514 |
| 56 | OXSR1 | 0.83779057 |
| 57 | CDK11A | 0.83542720 |
| 58 | MAP3K11 | 0.82849971 |
| 59 | CAMK4 | 0.82428646 |
| 60 | DAPK1 | 0.79792313 |
| 61 | MAP3K13 | 0.79554701 |
| 62 | PKN1 | 0.79530513 |
| 63 | PDK1 | 0.77078850 |
| 64 | STK39 | 0.76986376 |
| 65 | EEF2K | 0.76286151 |
| 66 | CDC42BPA | 0.75353218 |
| 67 | MAP3K12 | 0.75015095 |
| 68 | PDPK1 | 0.74664582 |
| 69 | CAMK2A | 0.74602607 |
| 70 | CASK | 0.74105363 |
| 71 | TNK2 | 0.73939644 |
| 72 | MAPK13 | 0.72533137 |
| 73 | SMG1 | 0.71846009 |
| 74 | PLK2 | 0.71014952 |
| 75 | MAP3K1 | 0.69687827 |
| 76 | CAMK2G | 0.69657198 |
| 77 | MAP3K7 | 0.69540953 |
| 78 | LIMK1 | 0.68577918 |
| 79 | CAMK2D | 0.67653678 |
| 80 | BRSK1 | 0.67347241 |
| 81 | ICK | 0.64123390 |
| 82 | SGK3 | 0.62738951 |
| 83 | DAPK3 | 0.61567449 |
| 84 | ROCK2 | 0.61439593 |
| 85 | IRAK2 | 0.61113044 |
| 86 | SCYL2 | 0.60566765 |
| 87 | PRKD1 | 0.60261005 |
| 88 | TAOK2 | 0.59601247 |
| 89 | MAPKAPK5 | 0.59332543 |
| 90 | MAPK10 | 0.58530156 |
| 91 | PDGFRA | 0.57479387 |
| 92 | PNCK | 0.57457818 |
| 93 | RPS6KA3 | 0.55444501 |
| 94 | SGK2 | 0.55434134 |
| 95 | NEK6 | 0.55139962 |
| 96 | BMX | 0.55004098 |
| 97 | SGK1 | 0.53654351 |
| 98 | SIK1 | 0.52043127 |
| 99 | BMPR2 | 0.51717439 |
| 100 | RAF1 | 0.51072885 |
| 101 | TRIB3 | 0.50687117 |
| 102 | DMPK | 0.50570112 |
| 103 | TNIK | 0.48584749 |
| 104 | FGFR2 | 0.47814671 |
| 105 | FYN | 0.47141848 |
| 106 | MOS | 0.46327294 |
| 107 | DYRK1A | 0.45747337 |
| 108 | CSNK1G2 | 0.45246662 |
| 109 | WNK4 | 0.44247562 |
| 110 | PRKCZ | 0.44226292 |
| 111 | CAMK1G | 0.42974520 |
| 112 | ROCK1 | 0.41444279 |
| 113 | PRKD2 | 0.40306072 |
| 114 | HIPK2 | 0.40108649 |
| 115 | MAP2K1 | 0.39137118 |
| 116 | RPS6KA2 | 0.37676632 |
| 117 | PTK2 | 0.33262083 |
| 118 | MAPK8 | 0.32425668 |
| 119 | MAPK4 | 0.31548343 |
| 120 | AKT2 | 0.30286894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34028181 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.06615566 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.75135438 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.69809413 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64674352 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.60162382 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.40674582 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.37806318 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.29092672 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.19241227 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.11782940 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.06595879 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01703343 |
| 14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.95173526 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91960054 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88524492 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.88003567 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74756559 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.74254093 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.64675306 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.58402027 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.51654867 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.49407345 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.48185773 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.48041289 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45415866 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41198002 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40456876 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38886720 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.37304820 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30317530 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29810552 |
| 33 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22920109 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22618080 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20944124 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08968270 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08419241 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07962537 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.06252295 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03467618 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01165713 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98472517 |
| 43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98113879 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96268705 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 0.95684121 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95494499 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94650733 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94188851 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90413512 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.89549224 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89253509 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83503485 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81453730 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 0.80660151 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80573680 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77704456 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77380458 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74990804 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.74858105 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73847261 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73188081 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70456752 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70439590 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69936796 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69417302 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68195146 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67642327 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67304653 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65817378 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64888858 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64586581 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63944297 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59070187 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59017001 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57705191 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55394828 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55313303 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54696209 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53827051 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51758249 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50461282 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.48859118 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48810973 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48761549 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48690117 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47326954 |
| 87 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46188837 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45780603 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45572765 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42655118 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42645616 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42405443 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41958630 |
| 94 | Alcoholism_Homo sapiens_hsa05034 | 0.41253223 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40380555 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39250531 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38614261 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.38231487 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37669256 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36653706 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36432344 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36344938 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36131191 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34663097 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34369544 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33160116 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.32321087 |
| 108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32187595 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31996083 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27454243 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25996452 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25208581 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.22516634 |

